Trial intelligence / Profile preview

Isobide and Meniace for Meniere's Disease

NCT02718846Phase 4Completed

Sponsor
Alvogen
Start
Feb 2013
Primary completion
May 2015
Modality
Small Molecules
01

Overview

A Phase 4 trial of Isosorbide oral solution (Lunan Better Pharmaceutical) in Meniere's disease (MD), sponsored by Alvogen. Started Feb 2013; status: completed.

02

Drugs

Isosorbide oral solution (Lunan Better Pharmaceutical)
03

Conditions

Meniere's disease (MD)

Beyond the preview

Go deeper on NCT02718846.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02718846.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call